Monthly Cost Comparison: Wegovy vs Mounjaro UK
Key Mounjaro and Wegovy Difference in Monthly Costs
The primary mounjaro and wegovy difference lies in their monthly cost structure and mechanism of action. Wegovy follows a 16-week dose escalation starting at £79.99 monthly, reaching £209.99 for the 2.4mg maintenance dose. This GLP-1 receptor agonist offers predictable pricing throughout your treatment journey. Mounjaro, as a dual GIP and GLP-1 agonist, follows a different escalation pattern with varying monthly costs. Both require clinical assessment and ongoing prescriber support.
Understanding the mounjaro and wegovy difference in cost helps you budget effectively for weight management. Wegovy's transparent pricing structure allows clear financial planning across the 16-week escalation period. Your total monthly commitment includes the prescription-only medicine cost plus any clinical monitoring required. Both treatments must be used alongside a reduced-calorie diet and increased physical activity for optimal results.
Detailed Wegovy Monthly Cost Breakdown UK
The mounjaro and wegovy difference in UK pricing becomes clear when examining Wegovy's month-by-month costs. Weeks 1-4 cost £79.99 with the 0.25mg starter dose, rising to £94.99 for weeks 5-8 (0.5mg). The 1mg dose for weeks 9-12 costs £99.99, followed by £139.99 for the 1.7mg dose (weeks 13-16). From week 17 onwards, the maintenance 2.4mg dose costs £209.99 monthly.
This mounjaro and wegovy difference in cost progression reflects the mandatory dose escalation required for both treatments. New customers apply code FIRST40 at checkout, while returning patients use DOSE25 to maintain consistent pricing. Our bundle options provide convenience rather than savings—the Intro Trio (0.25mg, 0.5mg, 1mg) costs £299.99 for three months of escalation doses. The Ultimate Stability Trio offers three months of 2.4mg maintenance supply for £649.99.
Clinical Evidence Supporting Mounjaro and Wegovy Difference
The mounjaro and wegovy difference extends beyond cost to clinical outcomes from separate trial programmes. In the STEP trials, patients taking Wegovy alongside diet and exercise achieved average weight reductions of approximately 15% at 68 weeks (Wilding et al., NEJM, 2021). The SELECT trial demonstrated a 20% reduction in major cardiovascular events among participants receiving semaglutide.
When considering the mounjaro and wegovy difference, both treatments showed significant results in their respective clinical programmes. However, direct head-to-head comparisons aren't available due to different trial designs and populations. Your prescriber at EverydayMeds can review both options during your clinical assessment, helping determine which prescription-only medicine aligns with your medical history and treatment goals.
How Wegovy Works: Understanding the Mechanism
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics a natural fullness hormone in your digestive system. This mechanism helps reduce appetite by signalling satiety to your brain's appetite centres after smaller meals. The once-weekly injection works continuously to promote feelings of fullness and may reduce food cravings throughout the week. Unlike some weight management approaches, Wegovy targets the biological pathways that regulate hunger and satiety. This prescription-only medicine requires ongoing medical supervision to monitor your response and adjust treatment as needed.
EverydayMeds Ordering Process for Weight Management
Accessing either treatment through EverydayMeds starts with our 3-minute online clinical assessment covering your medical history and weight management goals. Our UK-registered prescribers (GPhC #9012878) review your application within 3 working days, or 24 hours with express service. Once approved, your treatment ships via next-day cold-chain delivery maintaining the required 2-8°C temperature throughout transport. Our clinical team remains available for ongoing support throughout your treatment journey. The streamlined process ensures you can begin your weight management programme quickly while maintaining full medical oversight.
Storage and Practical Considerations
A key mounjaro and wegovy difference lies in storage flexibility—Wegovy remains stable for 6 weeks at room temperature below 30°C once removed from refrigeration, compared to Mounjaro's 21-day limit. Both arrive in the refrigerator-friendly FlexTouch pen system for once-weekly self-injection. The dose escalation schedule is mandatory for both treatments, requiring gradual increases over 16 weeks to reach maintenance dosing. Wegovy pens should be stored in the refrigerator at 2-8°C before first use, making travel and storage more convenient than some alternatives. Your initial supply includes clear instructions for proper storage and injection technique to ensure treatment effectiveness.
Annual Cost Planning for Long-Term Weight Management
When evaluating the mounjaro and wegovy difference for annual budgeting, Wegovy's maintenance cost of £209.99 monthly totals approximately £2,520 annually once you reach the 2.4mg dose. The initial 16-week escalation period costs £414.96 total across all starter doses. Returning customers benefit from code DOSE25 applied at checkout, ensuring consistent pricing throughout their treatment journey.
This mounjaro and wegovy difference in annual cost structure helps you plan long-term financial commitment for weight management. Clinical trials suggest weight regain occurs when treatment stops, making ongoing treatment crucial for sustained results. Our bundle options like the Ultimate Stability Trio provide three months of maintenance supply, reducing the frequency of orders while ensuring uninterrupted treatment access through our GPhC-registered pharmacy.
Making Your Treatment Decision
Both Wegovy and Mounjaro are available from EverydayMeds—your prescriber can help determine which is right for your specific situation and budget. The mounjaro and wegovy difference encompasses mechanism of action, cost structure, and storage requirements, but both require the same commitment to dietary changes and physical activity. Our clinical assessment evaluates your medical history, current medications, and weight management goals to recommend the most suitable option. During your consultation, discuss both the clinical benefits and monthly cost implications to make an informed decision. Remember that successful weight management represents a long-term investment in your health, making monthly cost predictability essential for sustained treatment adherence.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
